Article

A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention

The cost of heart disease is a growing burden on the healthcare system. As new technologies for treating heart disease become available, decision-makers need to understand their options. It is important to understand the short-term and long-term options, as well as the costs associated with these new technologies. This article uses big data analytics to take a look at the cost-effectiveness of a new heart pump technology to assist decision-makers in forming a value-based judgment relative to its application.

Read the full article.

Healthcare added 49,100 jobs in March, the most of any sector
Next up

2015 MedPAC report to Congress: Recommendations for inpatient and outpatient hospital services and ambulatory surgical centers